Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cloning and expression of a β-galactosidase gene of Bacillus circulans.
Song J, Imanaka H, Imamura K, Minoda M, Katase T, Hoshi Y, Yamaguchi S, Nakanishi K. Song J, et al. Among authors: hoshi y. Biosci Biotechnol Biochem. 2011;75(6):1194-7. doi: 10.1271/bbb.110014. Epub 2011 Jun 13. Biosci Biotechnol Biochem. 2011. PMID: 21670516 Free article.
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer.
Hirai T, Naito Y, Koyama S, Nakanishi Y, Masuhiro K, Izumi M, Kuge T, Naito M, Mizuno Y, Yamaguchi Y, Kang S, Yaga M, Futami Y, Nojima S, Nishide M, Morita T, Kato Y, Tsuda T, Takemoto N, Kinugasa-Katayama Y, Aoshi T, Villa JK, Yamashita K, Enokida T, Hoshi Y, Matsuura K, Tahara M, Takamatsu H, Takeda Y, Inohara H, Kumanogoh A. Hirai T, et al. Among authors: hoshi y. JCI Insight. 2024 Feb 8;9(3):e166349. doi: 10.1172/jci.insight.166349. JCI Insight. 2024. PMID: 38329122 Free PMC article.
Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck.
Tanaka H, Enokida T, Okano S, Fujisawa T, Tanaka N, Takeshita N, Onaga R, Hoshi Y, Wada A, Sato M, Ueda Y, Tahara M. Tanaka H, et al. Among authors: hoshi y. Front Oncol. 2023 Nov 21;13:1221352. doi: 10.3389/fonc.2023.1221352. eCollection 2023. Front Oncol. 2023. PMID: 38074688 Free PMC article.
Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).
Takeshita N, Enokida T, Okano S, Fujisawa T, Wada A, Sato M, Tanaka H, Tanaka N, Onaga R, Hoshi Y, Sakashita S, Ishii G, Tahara M. Takeshita N, et al. Among authors: hoshi y. Oral Oncol. 2023 Dec;147:106615. doi: 10.1016/j.oraloncology.2023.106615. Epub 2023 Nov 4. Oral Oncol. 2023. PMID: 37931493
493 results